Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia

References

• Akil M, Edgar CL, Pierri JN, Casali S, Lewis DA. 2000. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol Psychiatry. 47:361–370.
   PubMed Web of Science ®Google Scholar
• Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, Lewis DA. 1999. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry. 156:1580–1589.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders 5th ed. Arlington (VA): American Psychiatric Publishing.
   Google Scholar
• Babcock DF, Hille B. 1998. Mitochondrial oversight of cellular Ca2+ signaling. Curr Opin Neurobiol. 8:398–404.
   PubMed Web of Science ®Google Scholar
• Barker DJ, Root DH, Zhang S, Morales M. 2016. Multiplexed neurochemical signaling by neurons of the ventral tegmental area. J Chem Neuroanat. 73:33–42.
   PubMed Web of Science ®Google Scholar
• Benarroch EE. 2008. Subthalamic nucleus and its connections: Anatomic substrate for the network effects of deep brain stimulation. Neurology. 70:1991–1995.
   PubMed Web of Science ®Google Scholar
• Bolding MS, Reid MA, Avsar KB, Roberts RC, Gamlin PD, Gawne TJ, White DM, den Hollander JA, Lahti AC. 2013. Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biol Psychiatry. 73:289–294.
   PubMed Web of Science ®Google Scholar
• Carlsson A, Lindqvist M. 1963. Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse Brain. Acta Pharmacol Toxicol (Copenh). 20:140–144.
   PubMedGoogle Scholar
• Charara A, Smith Y, Parent A. 1996. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol. 364:254–266.
   PubMed Web of Science ®Google Scholar
• Chiodo LA, Bunney BS. 1987. Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences. J Neurosci. 7:629–633.
   PubMed Web of Science ®Google Scholar
• Coyle JT. 2006. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol. 26:365–384.
   PubMed Web of Science ®Google Scholar
• Creese I, Burt DR, Snyder SH. 1976. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 192:481–483.
   PubMed Web of Science ®Google Scholar
• Fallon JH, Riley JN, Moore RY. 1978. Substantia nigra dopamine neurons: separate populations project to neostriatum and allocortex. Neuroscience Lett. 7:157–162.
   PubMed Web of Science ®Google Scholar
• Fasulo WH, Hemby SE. 2003. Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. J Neurochem. 87:205–219.
   PubMed Web of Science ®Google Scholar
• Goldman-Rakic PS. 1994. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci. 6:348–357.
   PubMed Web of Science ®Google Scholar
• Graham DG. 1979. On the origin and significance of neuromelanin. Arch Pathol Lab Med. 103:359–362.
   PubMed Web of Science ®Google Scholar
• Gray EG. 1969. Electron microscopy of excitatory and inhibitory synapses: a brief review. Prog Brain Res. 31:141–155. Review.
   PubMedGoogle Scholar
• Gunter TE, Gunter KK, Sheu SS, Gavin CE. 1994. Mitochondrial calcium transport: physiological and pathological relevance. Am J Physiol. 267:C313–339.
   PubMedGoogle Scholar
• Haber SN. 2014. The place of dopamine in the cortico-basal ganglia circuit. Neuroscience. 282:248–257.
   PubMed Web of Science ®Google Scholar
• Haber SN, Fudge JL, McFarland NR. 2000. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci. 20:2369–2382.
   PubMed Web of Science ®Google Scholar
• Hadley J, Nenert R, Kraguljac NV, Bolding MS, White DM, Skidmore FM, Visscher KM, Lahti AC. 2014. Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology. 39:1020–1030.
   PubMedGoogle Scholar
• Halliday GM, Fedorow H, Rickert CH, Gerlach M, Riederer P, Double KL. 2006. Evidence for specific phases in the development of human neuromelanin. J Neural Transm (Vienna). 113:721–728.
   PubMed Web of Science ®Google Scholar
• Hassler R. 1938. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Pychol Neurol. 48:387–476.
   Google Scholar
• Hökfelt T, Fuxe K, Goldstein M. 1973. Immunohistochemical studies on monoamine-containing cell systems. Brain Res. 62:461–469.
   PubMed Web of Science ®Google Scholar
• Howes O, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S. 2012. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 69:776–786.
   PubMed Web of Science ®Google Scholar
• Howes O, Kapur S. 2009. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull. 35:549–562.
   PubMed Web of Science ®Google Scholar
• Howes O, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, Turkheimer F. 2013. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain. 136:3242–423251.
   PubMed Web of Science ®Google Scholar
• Ichinose H, Ohye T, Fujita K, Pantucek F, Lange K, Riederer P, Nagatsu T. 1994. Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia. J Neural Transm Gen Sect. 8:149–158.
   Web of Science ®Google Scholar
• Isaacs KR, Anderson BJ, Alcantara AA, Black JE, Greenough WT. 1992. Exercise and the brain: angiogenesis in the adult rat cerebellum after vigorous physical activity and motor skill learning. J Cereb Blood Flow Metab. 12:110–119.
   PubMed Web of Science ®Google Scholar
• Javitt DC. 2004. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry. 9:984–979.
   PubMed Web of Science ®Google Scholar
• Javitt DC. 2010. Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci. 47:4–16.
   PubMed Web of Science ®Google Scholar
• Kane JM, Honigfeld G, Singer J, Meltzer H. 1988. Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull. 24:62–67.
   PubMedGoogle Scholar
• Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M. 2010. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry. 67:231–239.
   PubMed Web of Science ®Google Scholar
• Kolomeets NS, Uranova NA. 1999. Synaptic contacts in schizophrenia: studies using immunocytochemical identification of dopaminergic neurons. Neurosci Behav Physiol. 29:217–221.
   PubMedGoogle Scholar
• Krueger-Burg D, Papadopoulos T, Brose N. 2017. Organizers of inhibitory synapses come of age. Curr Opin Neurobiol. 45:66–77.
   PubMed Web of Science ®Google Scholar
• Lavoie B, Parent A. 1990. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp Neurol. 299:1–16.
   PubMed Web of Science ®Google Scholar
• Lewis DA. 2000a. Distributed disturbances in brain structure and function in schizophrenia. Am J Psychiatry. 157:1–2.
   PubMed Web of Science ®Google Scholar
• Lewis DA. 2000b. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Brain Res Rev. 31:270–276.
   PubMedGoogle Scholar
• Li Z, Okamoto KI, Hayashi Y, Sheng M. 2004. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell. 119:873–887.
   PubMed Web of Science ®Google Scholar
• Mabry SJ, Bloom ES, McCollum LA, Roberts RC. 2017. Glutamate and GABA in the substantia nigra in postmortem brain. Schizophr Bull. 43:S196–S197.
   Google Scholar
• Mann DMA, Yates PO. 1974. Lipoprotein pigments-Their relationship to ageing in the human nervous system 11. The melanin content of pigmented nerve cells. Brain. 97:t489–498.
   PubMed Web of Science ®Google Scholar
• McCollum LA, McCullumsmith RE, Roberts RC. 2016. Tyrosine hydroxylase localization in the nucleus accumbens in schizophrenia. Brain Struct Funct. 221:4451–4458.
   PubMed Web of Science ®Google Scholar
• McCollum LA, Walker CK, Roche JK, Roberts RC. 2015. Elevated excitatory input to the nucleus accumbens in schizophrenia: a postmortem ultrastructural study. Schizophr Bull. 41:1123–1132.
   PubMed Web of Science ®Google Scholar
• McCullumsmith RE, O’Donovan SM, Drummond JB, Benesh FS, Simmons M, Roberts R, Lauriat T, Haroutunian V, Meador-Woodruff JH. 2016. Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons? Mol Psychiatry. 21:823–830.
   PubMed Web of Science ®Google Scholar
• McRitchie DA, Halliday GM, Cartwright H. 1995. Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience. 68:539–551.
   PubMed Web of Science ®Google Scholar
• McRitchie DA, Hardman CD, Halliday GM. 1996. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol. 364:121–150.
   PubMed Web of Science ®Google Scholar
• Miller KE, Sheetz MP. 2004. Axonal mitochondrial transport and potential are correlated. J Cell Sci. 117: 2791–2804.
   PubMed Web of Science ®Google Scholar
• Mueller T, Haroutunian V, Davis KL, Meador-Woodruff JH. 2004. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Mol Brain Res. 121:60–69.
   PubMedGoogle Scholar
• Parent A, Hazrati LN. 1995a. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev. 20:91–127.
   PubMed Web of Science ®Google Scholar
• Parent A, Hazrati LN. 1995b. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev. 20:128–154.
   PubMed Web of Science ®Google Scholar
• Parent M, Parent A, Charara A. 1999. Glutamatergic inputs to midbrain dopaminergic neurons in primates. Parkinsonism Relat Disord. 5:193–201.
   PubMed Web of Science ®Google Scholar
• Perez-Costas E, Melendez-Ferro M, Rice MW, Conley RR, Roberts RC. 2012. Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra. Front Psychiatry. 3:31.
   PubMedGoogle Scholar
• Perez-Costas E, Melendez-Ferro M, Roberts RC. 2010. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem. 113:287–302.
   PubMed Web of Science ®Google Scholar
• Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y. 2006. Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol. 499:231–243.
   PubMed Web of Science ®Google Scholar
• Rice M, Roberts RC, Melendez-Ferro M, Perez-Costas E. 2016. Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia. Brain Struct Funct. 221:185–201.
   PubMed Web of Science ®Google Scholar
• Roberts RC. 2017. Postmortem studies on mitochondria in schizophrenia. Schizophr Res. 187:17–25.
   PubMed Web of Science ®Google Scholar
• Roberts RC, Barksdale KA, Roche JK, Lahti AC. 2015. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia. Schizophr Res. 168:543–553.
   PubMed Web of Science ®Google Scholar
• Roberts RC, Gaither LA, Gao XM, Kashyap SM, Tamminga CA. 1995. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse. 20:234–243.
   PubMed Web of Science ®Google Scholar
• Root DH, Wang HL, Liu B, Barker DJ, Mód L, Szocsics P, Silva AC, Maglóczky Z, Morales M. 2016. Glutamate neurons are intermixed with midbrain dopamine neurons in nonhuman primates and humans. Sci Rep. 6:30615.
   PubMed Web of Science ®Google Scholar
• Schoonover KE, McCollum LA, Roberts RC. 2017. Protein markers of neurotransmitter synthesis and release in postmortem schizophrenia substantia nigra. Neuropsychopharmacology. 42:540–550.
   PubMed Web of Science ®Google Scholar
• Seeman P, Lee T, Chau-Wong M, Wong K. 1976. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:717–719.
   PubMed Web of Science ®Google Scholar
• Shibata E, Sasaki M, Tohyama K, Otsuka K, Endoh J, Terayama Y, Sakai A. 2008. Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry. 64:401–406.
   PubMed Web of Science ®Google Scholar
• Shoja SS, Jafarabad MS, Azizi R. 2015. Amelioration of deficit syndrome of schizophrenia by norepinephrine reuptake inhibitor. Ther Adv Psychopharmacol. 5:263–270.
   PubMed Web of Science ®Google Scholar
• Smith Y, Charara A, Parent A. 1996. Synaptic innervation of midbrain dopaminergic neurones by glutamate-enriched terminals in the squirrel monkey. J Comp Neurol. 364:231–253.
   PubMed Web of Science ®Google Scholar
• Smith ID, Grace AA. 1992. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse. 12:287–303.
   PubMed Web of Science ®Google Scholar
• Sotoyama H, Namba H, Chiken S, Nambu A, Nawa H. 2013. Exposure to the cytokine EGF leads to abnormal hyperactivity of pallidal GABA neurons: implications for schizophrenia and its modeling. J Neurochem. 126:518–528.
   PubMed Web of Science ®Google Scholar
• Spokes EG, Garrett NJ, Rossor MN, Iversen LL. 1980. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects. J Neurol Sci. 48:303–313.
   PubMed Web of Science ®Google Scholar
• Storm-Mathisen J. 1974. GABA as a transmitter in the central nervous system of vertebrates. J Neural Transm. 11:227–253.
   Google Scholar
• Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, et al. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441–446.
   PubMed Web of Science ®Google Scholar
• Tanaka S. 2006. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective. Neurosci. 139:153–171.
   PubMed Web of Science ®Google Scholar
• Tepper JM, Lee CR. 2007. GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res. 160:189–208.
   PubMed Web of Science ®Google Scholar
• Toru M, Watanabe S, Shibuya H, Nishikawa T, Noda K, Mitsushio H, Ichikawa H, Kurumaji A, Takashima M, Mataga N, Ogawa A. 1988. Neurotransmitters, receptors, and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand. 78:121–137.
   PubMed Web of Science ®Google Scholar
• Uranova NA, Levite OI. 1987. [Ultrastructure of the substantia nigra in schizophrenia]. Zh Nevropatol Psikhiatr IM S S Korsakova. 87:1017–1024.
   PubMedGoogle Scholar
• Vigneault É, Poirel O, Riad M, Prud'homme J, Dumas S, Turecki G, Fasano C, Mechawar N, El Mestikawy S. 2015. Distribution of vesicular glutamate transporters in the human brain. Front Neuroanat. 9:23.
   PubMed Web of Science ®Google Scholar
• Walker CK, Roche JK, Sinha V, Roberts RC. 2017. Substantia nigra ultrastructural pathology in schizophrenia. Schizophrenia Res. 197:209–218.
   Web of Science ®Google Scholar
• Watanabe Y, Tanaka A, Tsukabe A, Kunitomi Y, Nishizawa M, Hashimoto R, Yamamori H, Fujimoto M, Fukunaga M, Tomiyama N. 2014. Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia. PLoS One. 9:e104619.
   PubMed Web of Science ®Google Scholar
• Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A. 2017. Pathway-specific dopamine abnormalities in schizophrenia. Biol Psychiatry. 81:31–42.
   PubMed Web of Science ®Google Scholar
• White DM, Kraguljac NV, Reid MA, Lahti AC. 2015. Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study. NPJ Schizophr. 1:14001.
   PubMed Web of Science ®Google Scholar
• Williams MR, Galvin K, O’Sullivan B, MacDonald CD, Ching EWK, Turkheimer F, Howes OD, Pearce RKB, Hirsch SR, Maier M. 2014. Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci. 264:285–296.
   PubMed Web of Science ®Google Scholar
• Williams SM, Goldman-Rakic PS. 1998. Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex. 8:321–345.
   PubMed Web of Science ®Google Scholar
• Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G. 2005. Presynaptic regulation of quantal size by the vesicular glutamate transporter vGLUT1. J Neurosci. 25:6221–6234.
   PubMed Web of Science ®Google Scholar
• Wong-Riley MT. 1989. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12: 94–101.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Minzenberg MJ, Raouf S, D’Esposito M, Carter CS. 2013. Impaired prefrontostriatonigral functional connectivity and substantia nigra hyperactivity in schizophrenia. Biol Psychiatry. 74:122–129.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Westphal AJ, Minzenberg MJ, Niendam T, Ragland JD, Lesh T, Solomon M, Carter CS. 2014. Task-evoked substantia nigra hyperactivity associated with prefrontal hypofunction, prefrontonigral disconnectivity and nigrostriatal connectivity predicted psychosis severity in medication naïve first episode schizophrenia. Schizophrenia Res. 159:521–526.
   PubMed Web of Science ®Google Scholar